Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stangel

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Der Nervenarzt|October 12, 2002
[Transplantation of myelinating cells as regenerative therapy for multiple sclerosis - experimental basis and present state of clinical studies]M Stangel
Current Pharmaceutical Design|February 4, 2006
Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosisC Trebst, M Stangel
International MS Journal|June 16, 2005
Intravenous Immunoglobulins in MSM Stangel, R Gold
Journal of Neuroimmunology|December 8, 2000
Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptorsM Stangel, A Compston
Der Nervenarzt|May 20, 2005
[High-dose intravenous immunoglobulins in the treatment of multiple sclerosis. An update]M Stangel, R Gold
Brain Research. Developmental Brain Research|May 18, 2001
Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cellsD Nguyen, M Stangel
Deutsche Medizinische Wochenschrift (1946)|September 13, 1996
[A quickly reversible occlusion in the vertebrobasilar circulatory bed: often unrecognized?]M Stangel, F Boegner
Der Nervenarzt|June 26, 2010
[Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010]M Stangel, R Gold
Der Nervenarzt|June 30, 2004
[Use of i.v. immunoglobulins in neurology. Evidence-based consensus]M Stangel, R Gold
Fortschritte Der Neurologie-Psychiatrie|July 30, 2005
[Cannabinoids in multiple sclerosis -- therapeutically reasonable?]C Trebst, M Stangel
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Der Nervenarzt|October 12, 2002
[Transplantation of myelinating cells as regenerative therapy for multiple sclerosis - experimental basis and present state of clinical studies]M Stangel
Current Pharmaceutical Design|February 4, 2006
Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosisC Trebst, M Stangel
International MS Journal|June 16, 2005
Intravenous Immunoglobulins in MSM Stangel, R Gold
Journal of Neuroimmunology|December 8, 2000
Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptorsM Stangel, A Compston
Der Nervenarzt|May 20, 2005
[High-dose intravenous immunoglobulins in the treatment of multiple sclerosis. An update]M Stangel, R Gold
Brain Research. Developmental Brain Research|May 18, 2001
Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cellsD Nguyen, M Stangel
Deutsche Medizinische Wochenschrift (1946)|September 13, 1996
[A quickly reversible occlusion in the vertebrobasilar circulatory bed: often unrecognized?]M Stangel, F Boegner
Der Nervenarzt|June 26, 2010
[Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010]M Stangel, R Gold
Der Nervenarzt|June 30, 2004
[Use of i.v. immunoglobulins in neurology. Evidence-based consensus]M Stangel, R Gold
Fortschritte Der Neurologie-Psychiatrie|July 30, 2005
[Cannabinoids in multiple sclerosis -- therapeutically reasonable?]C Trebst, M Stangel
Pageof 7